Investor IP Group plc posted a positive outlook for the first six months of 2025, highlighting the IPO of portfolio company Hinge Health in New York and similarly strong performance of Oxford Nanopore, which beat guidance with £105.6m revenues in H1 and lower EBITDA losses.

IP Group, which invests in breakthrough science and innovation companies, said £372m total capital was raised by its portfolio (HY24: £380m) while it invested £36m across 21 companies. It saw total cash proceeds from exits of £30.3m, exceeding HY24 proceeds by 9x.

It remains confident of its target to deliver over £250m of exits between 2025 and 2027.